Globe Life Inc. $GL Stock Holdings Raised by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership lifted its holdings in Globe Life Inc. (NYSE:GL) by 32.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,435,247 shares of the company’s stock after buying an additional 355,399 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Globe Life were worth $200,734,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Globe Life by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after acquiring an additional 607 shares during the period. NewEdge Advisors LLC increased its stake in Globe Life by 368.1% during the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after buying an additional 5,352 shares during the period. Goldman Sachs Group Inc. increased its stake in Globe Life by 11.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after buying an additional 58,163 shares during the period. Empowered Funds LLC acquired a new position in Globe Life during the 1st quarter valued at about $428,000. Finally, Focus Partners Wealth increased its stake in Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after buying an additional 656 shares during the period. 81.61% of the stock is currently owned by institutional investors.

Insider Activity at Globe Life

In related news, EVP Michael Clay Majors sold 34,000 shares of the firm’s stock in a transaction that occurred on Friday, April 24th. The shares were sold at an average price of $153.81, for a total transaction of $5,229,540.00. Following the completion of the sale, the executive vice president directly owned 53,518 shares in the company, valued at approximately $8,231,603.58. This trade represents a 38.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $156.59, for a total transaction of $1,242,698.24. Following the completion of the sale, the chief financial officer owned 50,496 shares of the company’s stock, valued at $7,907,168.64. This trade represents a 13.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 105,929 shares of company stock valued at $16,382,450. 2.11% of the stock is owned by company insiders.

Globe Life Stock Performance

GL stock opened at $166.75 on Monday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The stock has a market cap of $12.95 billion, a P/E ratio of 11.53 and a beta of 0.49. The firm has a 50 day simple moving average of $152.88 and a 200 day simple moving average of $144.60. Globe Life Inc. has a 52 week low of $116.73 and a 52 week high of $168.27.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). The company had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Research analysts anticipate that Globe Life Inc. will post 15.64 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Keefe, Bruyette & Woods reissued a “moderate buy” rating and set a $168.00 target price on shares of Globe Life in a research note on Thursday, March 26th. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. Piper Sandler raised their target price on shares of Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a research note on Tuesday, May 26th. Wells Fargo & Company raised their target price on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, April 10th. Finally, Texas Capital raised shares of Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $174.11.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.